视网母细胞瘤和 D 酶

The contribution of USH1C mutations to syndromic and non-syndromic deafness in the UK.

Clinical genetics·2003

A family study and the natural history of prenatally detected unilateral multicystic dysplastic kidney.

The Journal of urology·2002

Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.

Nature genetics·2001

A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment.

Journal of medical genetics·2001

Multiple origins of the mtDNA 7472insC mutation associated with hearing loss and neurological dysfunction.

European journal of human genetics : EJHG·2001

Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment.

Journal of medical genetics·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Microbial technologies as an ecological tool for advancing environmental sustainability.

Frontiers in microbiology·2026

Sol-gel engineered xanthan gum/carboxymethyl cellulose/silica hybrid adsorbent for efficient removal of cationic and anionic dyes.

RSC advances·2026

A novel cold-adapted organophosphorus hydrolase and its application in whole-cell catalytic degradation of organophosphorus pesticides at low temperature.

International journal of biological macromolecules·2026

Efficient nitrate removal by photo-assisted microbial denitrification using FexOy/g-C3N4-biofilm hybrid in a coiled flow inverter.

Bioresource technology·2026

Perfluorobutane sulfonate reshapes microbial metabolism and enhances antibiotic resistance and pathogen dissemination in anammox systems.

Bioresource technology·2026

Transcriptome landscape unveils putative defense response in Chryseobacterium sp. strain PMSZPI against uranium toxicity.

World journal of microbiology & biotechnology·2026

相关实验视频

视网母细胞瘤和 D 酶

相关概念视频

The contribution of USH1C mutations to syndromic and non-syndromic deafness in the UK.

A family study and the natural history of prenatally detected unilateral multicystic dysplastic kidney.

Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.

A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment.

Multiple origins of the mtDNA 7472insC mutation associated with hearing loss and neurological dysfunction.

Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Microbial technologies as an ecological tool for advancing environmental sustainability.

Sol-gel engineered xanthan gum/carboxymethyl cellulose/silica hybrid adsorbent for efficient removal of cationic and anionic dyes.

A novel cold-adapted organophosphorus hydrolase and its application in whole-cell catalytic degradation of organophosphorus pesticides at low temperature.

Efficient nitrate removal by photo-assisted microbial denitrification using Fe<sub>x</sub>O<sub>y</sub>/g-C<sub>3</sub>N<sub>4</sub>-biofilm hybrid in a coiled flow inverter.

Perfluorobutane sulfonate reshapes microbial metabolism and enhances antibiotic resistance and pathogen dissemination in anammox systems.

Transcriptome landscape unveils putative defense response in Chryseobacterium sp. strain PMSZPI against uranium toxicity.

相关实验视频

视网母细胞瘤和 D 酶

相关概念视频

相关文章